• Explore /
  • Poster
  • / Right-sided colorectal cancer (RC): Response to first-line chemotherapy in FIRE-3 (AIO KRK-0306) with focus on early tumor shrinkage (ETS) and depth of response (DpR).

Right-sided colorectal cancer (RC): Response to first-line chemotherapy in FIRE-3 (AIO KRK-0306) with focus on early tumor shrinkage (ETS) and depth of response (DpR).

Abstract Poster

Authors

null

Julian Walter Holch

Department of Medical Oncology, Comprehensive Cancer Center Munich, University Hospital Grosshadern, Ludwig-Maximilians- University Munich, Munich, Germany

Julian Walter Holch , Sebastian Stintzing , Swantje Held , Ludwig Fischer von Weikersthal , Thomas Decker , Alexander Kiani , Ursula Vehling-Kaiser , Salah-Eddin Al-Batran , Tobias Heintges , Christoph Kahl , Frank Kullmann , Werner Scheithauer , Thomas Kirchner , Jobst C. von Einem , Dominik Paul Modest , Volker Heinemann

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Colorectal) Cancer

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Epidemiology/Outcomes

Citation

J Clin Oncol 35, 2017 (suppl; abstr 3586)

DOI

10.1200/JCO.2017.35.15_suppl.3586

Abstract #

3586

Poster Bd #

209

Abstract Disclosures

Similar Posters

First Author: Sebastian Stintzing

Poster

2013 Gastrointestinal Cancers Symposium

Predictive value of baseline CD66e/CEA serum levels on efficacy of bevacizumab-based treatment in advanced colorectal cancer.

Predictive value of baseline CD66e/CEA serum levels on efficacy of bevacizumab-based treatment in advanced colorectal cancer.

First Author: Gerald Prager

First Author: Sebastian Stintzing

First Author: Pilar Garcia-Alfonso